171 related articles for article (PubMed ID: 34828429)
1.
Christen M; Indzhova V; Guo LT; Jagannathan V; Leeb T; Shelton GD; Brocal J
Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828429
[TBL] [Abstract][Full Text] [Related]
2. Congenital muscular dystrophy in a dog with a LAMA2 gene deletion.
Shelton GD; Minor KM; Thomovsky S; Guo LT; Friedenberg SG; Cullen JN; Mickelson JR
J Vet Intern Med; 2022 Jan; 36(1):279-284. PubMed ID: 34854126
[TBL] [Abstract][Full Text] [Related]
3. Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD.
Moreira Soares Oliveira B; Durbeej M; Holmberg J
PLoS One; 2017; 12(8):e0181950. PubMed ID: 28771630
[TBL] [Abstract][Full Text] [Related]
4. Vemurafenib improves muscle histopathology in a mouse model of LAMA2-related congenital muscular dystrophy.
Oliveira-Santos A; Dagda M; Wittmann J; Smalley R; Burkin DJ
Dis Model Mech; 2023 Jun; 16(6):. PubMed ID: 37021539
[TBL] [Abstract][Full Text] [Related]
5. A single point mutation in the LN domain of LAMA2 causes muscular dystrophy and peripheral amyelination.
Patton BL; Wang B; Tarumi YS; Seburn KL; Burgess RW
J Cell Sci; 2008 May; 121(Pt 10):1593-604. PubMed ID: 18430779
[TBL] [Abstract][Full Text] [Related]
6. Substitution of a conserved cysteine-996 in a cysteine-rich motif of the laminin alpha2-chain in congenital muscular dystrophy with partial deficiency of the protein.
Nissinen M; Helbling-Leclerc A; Zhang X; Evangelista T; Topaloglu H; Cruaud C; Weissenbach J; Fardeau M; Tomé FM; Schwartz K; Tryggvason K; Guicheney P
Am J Hum Genet; 1996 Jun; 58(6):1177-84. PubMed ID: 8651294
[TBL] [Abstract][Full Text] [Related]
7. The zebrafish candyfloss mutant implicates extracellular matrix adhesion failure in laminin alpha2-deficient congenital muscular dystrophy.
Hall TE; Bryson-Richardson RJ; Berger S; Jacoby AS; Cole NJ; Hollway GE; Berger J; Currie PD
Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7092-7. PubMed ID: 17438294
[TBL] [Abstract][Full Text] [Related]
8. Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy.
Nguyen Q; Lim KRQ; Yokota T
Appl Clin Genet; 2019; 12():113-130. PubMed ID: 31308722
[TBL] [Abstract][Full Text] [Related]
9. Natural disease history of the dy2J mouse model of laminin α2 (merosin)-deficient congenital muscular dystrophy.
Pasteuning-Vuhman S; Putker K; Tanganyika-de Winter CL; Boertje-van der Meulen JW; van Vliet L; Overzier M; Plomp JJ; Aartsma-Rus A; van Putten M
PLoS One; 2018; 13(5):e0197388. PubMed ID: 29763467
[TBL] [Abstract][Full Text] [Related]
10. Muscular dystrophy in female dogs.
Shelton GD; Liu LA; Guo LT; Smith GK; Christiansen JS; Thomas WB; Smith MO; Kline KL; March PA; Flegel T; Engvall E
J Vet Intern Med; 2001; 15(3):240-4. PubMed ID: 11380033
[TBL] [Abstract][Full Text] [Related]
11. Effects of metformin on congenital muscular dystrophy type 1A disease progression in mice: a gender impact study.
Fontes-Oliveira CC; M Soares Oliveira B; Körner Z; M Harandi V; Durbeej M
Sci Rep; 2018 Nov; 8(1):16302. PubMed ID: 30389963
[TBL] [Abstract][Full Text] [Related]
12. Increased polyamines as protective disease modifiers in congenital muscular dystrophy.
Kemaladewi DU; Benjamin JS; Hyatt E; Ivakine EA; Cohn RD
Hum Mol Genet; 2018 Jun; 27(11):1905-1912. PubMed ID: 29566247
[TBL] [Abstract][Full Text] [Related]
13. Laminin alpha2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy.
Miyagoe Y; Hanaoka K; Nonaka I; Hayasaka M; Nabeshima Y; Arahata K; Nabeshima Y; Takeda S
FEBS Lett; 1997 Sep; 415(1):33-9. PubMed ID: 9326364
[TBL] [Abstract][Full Text] [Related]
14. Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice.
Ringelmann B; Röder C; Hallmann R; Maley M; Davies M; Grounds M; Sorokin L
Exp Cell Res; 1999 Jan; 246(1):165-82. PubMed ID: 9882526
[TBL] [Abstract][Full Text] [Related]
15. LAMA2-related myopathy: Frequency among congenital and limb-girdle muscular dystrophies.
Løkken N; Born AP; Duno M; Vissing J
Muscle Nerve; 2015 Oct; 52(4):547-53. PubMed ID: 25663498
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous muscular dystrophy caused by a retrotransposal insertion in the mouse laminin alpha2 chain gene.
Besse S; Allamand V; Vilquin JT; Li Z; Poirier C; Vignier N; Hori H; Guénet JL; Guicheney P
Neuromuscul Disord; 2003 Mar; 13(3):216-22. PubMed ID: 12609503
[TBL] [Abstract][Full Text] [Related]
17. A splice site mutation in laminin-α2 results in a severe muscular dystrophy and growth abnormalities in zebrafish.
Gupta VA; Kawahara G; Myers JA; Chen AT; Hall TE; Manzini MC; Currie PD; Zhou Y; Zon LI; Kunkel LM; Beggs AH
PLoS One; 2012; 7(8):e43794. PubMed ID: 22952766
[TBL] [Abstract][Full Text] [Related]
18. Laminin-111 protein therapy after disease onset slows muscle disease in a mouse model of laminin-α2 related congenital muscular dystrophy.
Barraza-Flores P; Bukovec KE; Dagda M; Conner BW; Oliveira-Santos A; Grange RW; Burkin DJ
Hum Mol Genet; 2020 Aug; 29(13):2162-2170. PubMed ID: 32472139
[TBL] [Abstract][Full Text] [Related]
19. Laminin α1 reduces muscular dystrophy in dy
Gawlik KI; Harandi VM; Cheong RY; Petersén Å; Durbeej M
Matrix Biol; 2018 Sep; 70():36-49. PubMed ID: 29544677
[TBL] [Abstract][Full Text] [Related]
20. Laminin and Integrin in LAMA2-Related Congenital Muscular Dystrophy: From Disease to Therapeutics.
Barraza-Flores P; Bates CR; Oliveira-Santos A; Burkin DJ
Front Mol Neurosci; 2020; 13():1. PubMed ID: 32116540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]